Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Declines By 8.3%

Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) was the recipient of a large drop in short interest in the month of November. As of November 30th, there was short interest totalling 42,100 shares, a drop of 8.3% from the November 15th total of 45,900 shares. Based on an average daily volume of 103,600 shares, the short-interest ratio is presently 0.4 days.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in EDAP. Redhawk Wealth Advisors Inc. bought a new stake in Edap Tms during the third quarter worth about $36,000. BNP Paribas Financial Markets lifted its position in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock worth $59,000 after buying an additional 4,400 shares during the last quarter. Orion Capital Management LLC boosted its stake in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock worth $178,000 after buying an additional 6,600 shares in the last quarter. Commonwealth Equity Services LLC grew its position in Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider's stock valued at $388,000 after acquiring an additional 4,000 shares during the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new position in shares of Edap Tms during the third quarter worth approximately $395,000. Institutional investors own 62.74% of the company's stock.

Edap Tms Price Performance

Shares of NASDAQ:EDAP traded up $0.03 during trading on Monday, reaching $2.23. The company had a trading volume of 128,862 shares, compared to its average volume of 73,759. Edap Tms has a 12 month low of $2.14 and a 12 month high of $8.50. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $82.74 million, a P/E ratio of -3.43 and a beta of 0.33. The company has a fifty day moving average of $2.56 and a two-hundred day moving average of $3.71.

Analyst Ratings Changes

EDAP has been the subject of several recent analyst reports. HC Wainwright restated a "buy" rating and set a $19.00 target price on shares of Edap Tms in a research report on Thursday, August 29th. StockNews.com raised Edap Tms from a "sell" rating to a "hold" rating in a report on Thursday, December 5th.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.